Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001600132-17-000024
Filing Date
2017-03-17
Accepted
2017-03-17 16:49:52
Documents
5
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a201610-kaauditorreportdate.htm 10-K/A 41568
2 EXHIBIT 23.1 blph12312016aex231.htm EX-23.1 3620
3 EXHIBIT 31.1 blph12312016aex311.htm EX-31.1 11972
4 EXHIBIT 31.2 blph12312016aex312.htm EX-31.2 11967
5 EXHIBIT 32 blph12312016aex32.htm EX-32 7896
  Complete submission text file 0001600132-17-000024.txt   78106
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36845 | Film No.: 17698673
SIC: 2834 Pharmaceutical Preparations